The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
Open accessAbstract
TMPRSS2 is an androgen-regulated cell-surface serine protease expressed predominantly in prostate epithelium. TMPRSS2 is expressed highly in localized high-grade prostate cancers and in the majority of human prostate cancer metastases. Through the generation of mouse models with a targeted deletion of Tmprss2, we demonstrate that the activity of this protease regulates cancer cell invasion and metastasis to distant organs. By screening combinatorial peptide libraries, we identified a spectrum of TMPRSS2 substrates that include pro-hepatocyte growth factor (HGF). HGF activated by TMPRSS2 promoted c-MET receptor tyrosine kinase signaling, and initiated a proinvasive epithelial-to-mesenchymal transition phenotype. Chemical library screens identified a potent bioavailable TMPRSS2 inhibitor that suppressed prostate cancer metastasis in vivo. Together, these findings provide a mechanistic link between androgen-regulated signaling programs and prostate cancer metastasis that operate via context-dependent interactions with extracellular constituents of the tumor microenvironment. Significance: The vast majority of prostate cancer deaths are due to metastasis. Loss of TMPRSS2 activity dramatically attenuated the metastatic phenotype through mechanisms involving the HGF–c-MET axis. Therapeutic approaches directed toward inhibiting TMPRSS2 may reduce the incidence or progression of metastasis in patients with prostate cancer. Cancer Discov; 4(11); 1310–25. ©2014 AACR. See related commentary by Rubin, p. 1262 This article is highlighted in the In This Issue feature, p. 1243
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
Chiang, A. C., & Massagué, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0805239 · Cited by 1,054
Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Jänne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J., & Brown, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.041 · Cited by 687
Shappell, S. B., Thomas, G. V., Roberts, R. L., Herbert, R., Ittmann, M. M., Rubin, M. A., Humphrey, P. A., Sundberg, J. P., Rozengurt, N., Barrios, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0946 · Cited by 598
Lin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.-G., Ohgi, K. A., Zhang, J., Rose, D. W., Fu, X.-D., Glass, C. K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.030 · Cited by 576
Harris, J. L., Backes, B. J., Leonetti, F., Mahrus, S., Ellman, J. A., & Craik, C. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140132697 · Cited by 541
Self-citationInvasive growth: a MET-driven genetic programme for cancer and stem cells
Boccaccio, C., & Comoglio, P. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1912 · Cited by 538
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.
Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R. L., True, L. D., Hood, L., & Nelson, P. S. (1999) · PubMed · Cited by 531
Self-citationPathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model
Kaplan‐Lefko, P. J., Chen, T., Ittmann, M. M., Barrios, R. J., Ayala, G. E., Huss, W. J., Maddison, L. A., Foster, B. A., & Greenberg, N. M. (2003) · The Prostate · doi:10.1002/pros.10215 · Cited by 438
Choe, Y., Leonetti, F., Greenbaum, D. C., Lecaille, F., Bogyo, M., Brömme, D., Ellman, J. A., & Craik, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513331200 · Cited by 425
Self-citationAggressive Variants of Castration-Resistant Prostate Cancer
Beltran, H., Tomlins, S., Aparicio, A., Arora, V., Rickman, D., Ayala, G., Huang, J., True, L., Gleave, M. E., Soule, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3309 · Cited by 420
Self-citationExpression profiling reveals hepsin overexpression in prostate cancer.
Magee, J. A., Araki, T., Patil, S., Ehrig, T., True, L. D., Humphrey, P. A., Catàlona, W. J., Watson, M. A., & Milbrandt, J. (2001) · PubMed · Cited by 393
Self-citationHepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail
Grotegut, S., von Schweinitz, D., Christofori, G., & Lehembre, F. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601213 · Cited by 363
Type II Transmembrane Serine Proteases
Hooper, J. D., Clements, J. A., Quigley, J. P., & Antalis, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000020200 · Cited by 357
Tanaka, H., Kono, E., Tran, C. P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2236 · Cited by 339
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
Setlur, S. R., Mertz, K. D., Hoshida, Y., Demichelis, F., Lupien, M., Perner, S., Sboner, A., Pawitan, Y., Andrén, O., Johnson, L. A., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn150 · Cited by 328
Netzel-Arnett, S., Hooper, J. D., Szabo, R., Madison, E. L., Quigley, J. P., Bugge, T. H., & Antalis, T. M. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023003616848 · Cited by 289
Hepsin promotes prostate cancer progression and metastasis
Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R. L., Matusik, R. J., & Vasioukhin, V. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.008 · Cited by 282
Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
Jiang, W. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00019-5 · Cited by 264
Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3465 · Cited by 251
Arteaga, C. L., Tandon, A. K., Hoff, D. D. V., & Osborne, C. K. (1988) · PubMed · Cited by 245
Backes, B. J., Harris, J. L., Leonetti, F., Craik, C. S., & Ellman, J. A. (2000) · Nature Biotechnology · doi:10.1038/72642 · Cited by 242
Self-citationPhenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease
Kim, T. S., Heinlein, C., Hackman, R. C., & Nelson, P. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.965-975.2006 · Cited by 217
Self-citationType II transmembrane serine proteases
Szabo, R., Wu, Q., Dickson, R. B., Netzel-Arnett, S., Antalis, T. M., & Bugge, T. H. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0071 · Cited by 199
Type II transmembrane serine proteases in development and disease
Szabo, R., & Bugge, T. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.013 · Cited by 193
Corey, E., Quinn, J. E., Bladou, F., Brown, L. G., Roudier, M. P., Brown, J. M., Buhler, K. R., & Vessella, R. L. (2002) · The Prostate · doi:10.1002/pros.10091 · Cited by 192
Self-citationLuCaP 35: A new model of prostate cancer progression to androgen independence
Corey, E., Quinn, J. E., Buhler, K. R., Nelson, P. S., Macoska, J. A., True, L. D., & Vessella, R. L. (2003) · The Prostate · doi:10.1002/pros.10198 · Cited by 160
Self-citationSaleem, M., Adhami, V. M., Zhong, W., Longley, B. J., Lin, C.-Y., Dickson, R. B., Reagan-Shaw, S., Jarrard, D. F., & Mukhtar, H. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0737 · Cited by 158
LUCAS, J., True, L. D., Hawley, S. J., Matsumura, M., Morrissey, C. M., Vessella, R. L., & Nelson, P. (2008) · The Journal of Pathology · doi:10.1002/path.2330 · Cited by 139
Self-citationWeimar, I. S., Miranda, N., Muller, E. J., Hekman, A., Kerst, J., GAST, G. C. D., & Gerritsen, W. R. (1998) · PubMed · Cited by 135
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
Szabo, R., Rasmussen, A. L., Moyer, A. B., Kosa, P. F., Schafer, J. M., Molinolo, A., Gutkind, J. S., & Bugge, T. H. (2011) · Oncogene · doi:10.1038/onc.2010.586 · Cited by 106
Gmyrek, G. A., Walburg, M., Webb, C. P., Yu, H. I., You, X., Vaughan, E. D., Woude, G. F. V., & Knudsen, B. S. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61729-4 · Cited by 99
Conserved Gene Expression Programs Integrate Mammalian Prostate Development and Tumorigenesis
Pritchard, C. C., Mecham, B., Dumpit, R. F., Coleman, I. M., Bhattacharjee, M., Chen, Q., Sikes, R. A., & Nelson, P. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6817 · Cited by 78
Self-citationZhang, Y.-W., Su, Y., Lanning, N. J., Gustafson, M. F., Shinomiya, N., Zhao, P., Cao, B. B., Tsarfaty, G., Wang, L., Hay, R. V., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208181 · Cited by 74
Cited by
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Montopoli, M., Zumerle, S., Vettor, R., Rugge, M., Zorzi, M., Catapano, C. V., Carbone, G. M., Cavalli, A., Pagano, F., Ragazzi, E., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.479 · Cited by 518
TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
Stopsack, K. H., Mucci, L. A., Antonarakis, E. S., Nelson, P. S., & Kantoff, P. W. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0451 · Cited by 382
Self-citationMolecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 339
Bienvenu, L. A., Noonan, J., Wang, X., & Peter, K. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa284 · Cited by 338
Metadata
- Authors
- Lucas, J. M., Heinlein, C., Kim, T., Hernandez, S. A., Malik, M. S., True, L. D., Morrissey, C., Corey, E., Montgomery, B., Mostaghel, E., Clegg, N., Coleman, I., Brown, C. M., Schneider, E. L., Craik, C., Simon, J. A., Bedalov, A., & Nelson, P. S.
- Venue
- Cancer Discovery
- Published
- 2014-11-01
- Volume
- 4
- Issue
- 11
- Pages
- 1310-1325
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2134872401
- Cited by
- 468
- References
- 39
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.